Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.98
Delayed Data
As of Jul 19
 +0.02 / +0.68%
Today’s Change
2.58
Today|||52-Week Range
5.66
+3.47%
Year-to-Date

Today’s Trading

Previous close2.96
Today’s open2.97
Day’s range2.89 - 3.01
Volume792,825
Average volume (3 months)1,239,913
Market cap$409.5M
Data as of 4:00pm ET, 07/19/2018

Growth & Valuation

Earnings growth (last year)-37.78%
Earnings growth (this year)+9.35%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.26

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.35+1.73%
SGYPSynergy Pharmaceutic...-0.01-0.53%
INSYINSYS Therapeutics I...+0.14+1.72%
MGNXMacroGenics Inc+0.43+1.97%
Data as of 4:00pm ET, 07/19/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$85.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, COO &
Director
Joseph Truitt
CFO, Principal Accounting Officer &
Executive VP
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts